Merck & Co., Inc.

Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices.  
 

News

Moleculin Biotech, Inc. (NASDAQ:MBRX) is "One to Watch"

🕔8/1/2017 12:01:00 AM 4612

(NetworkNewsWire) For preclinical oncology biopharma Moleculin Biotech, Inc. (NASDAQ:MBRX), the quest to deliver potentially revolutionary anti-cancer drugs to the market is enkindled by a close association with The University of Texas MD Anderson Cancer Center.

Read Full Article
###

1,241 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 1) (Last 30 Days: 9) (Since Published: 1241) 

Company Data